About 1,172,462 results (3,774 milliseconds)

US20050287178A1 - Diagnosis and treatment of heavy gallbladder ...

https://patents.google.com/patent/US20050287178A1/en
... elevated liver enzymes and pancreatitis. [0008]. It would, therefore, be desirable to determine the pathological cause of at least one of these persisting ...

Hepatobiliary and Pancreatic - SurgicalSOP.com

https://sites.google.com/site/acutesurgicalcare/home/hepatobiliary-and-pancreatic
Cholecystostomy tube can be used for complicated cholecystitis (grade III) and allow subsequent laparoscopic cholecystectomy. It can also be used for high risk ...

English Springer Spaniel Health - Hepatitis (Chronic & Acute)

https://sites.google.com/site/englishspringerhealth/health-conditions/hepatitis
Medications: Certain drugs can cause side effects of liver damage that may progress to chronic hepatitis. ... level of liver enzymes on blood tests.

How to interpret your lab ... - Houston Thyroid & Endocrine Specialists

https://sites.google.com/houstonendocrine.com/website/patientportal/results-interpretation
LDH is the enzyme present in all the cells in the body. Anything which damages cells, including blood drawing itself, will raise amounts in the blood. If blood ...

US20210405075A1 - Nanoveson(TM): Treatment, Biomarkers and ...

https://patents.google.com/patent/US20210405075A1/en
It is hypothesized that through multiple Nanoveson™ therapy treatments lipid homeostasis in the liver can be obtained and elevated liver enzymes can be ...

US4198396A - Dissolution of gallstones - Google Patents

https://patents.google.com/patent/US4198396A/en
The cholesterol synthesized in the liver can be excreted into the bile ... A high caloric intake causes increased hepatic cholesterogenesis. This seems ...

US6638498B2 - Molecularly imprinted polymers for the treatment ...

https://patents.google.com/patent/US6638498B2/en
... removal of the gallbladder unless ... Cholesterol hypersecretion triggers events that lead to loss of gallbladder reservoir function leading to increased ...

RU2657838C1 - Method of prophylaxis of non-alcoholic fatty liver ...

https://patents.google.com/patent/RU2657838C1/en
But still, removal of the gallbladder does not eliminate the cholelithiasis ... gallstones, increased activity of “liver” transaminases, allergic reactions.

Phosphatidylcholine (PC) - Living with MTHFR

https://sites.google.com/view/livingwithmthfr/genetic-education/amino-acids/phosphatidylcholine-pc
Low levels of choline and phosphatidylcholine can cause non-alcoholic fatty liver disease (NAFLD) in humans. ... liver and returned his high liver enzymes back to ...

US20180055997A1 - Compartmentalized method of nucleic acid ...

https://patents.google.com/patent/US20180055997A1/en
Hence, the uses or compositions for use herein for direct delivery to the parenchyma of a compartmentalized tissue or organ or portion thereof can effect ...

CN105343793A - Traditional Chinese medicine composition for ...

https://patents.google.com/patent/CN105343793A/en
all can affect suffocating of liver and gall and transporting and transforming function ... liver dispelling the stagnated QI, effect that removing food ...

US11278591B2 - Compositions comprising choline - Google Patents

https://patents.google.com/patent/US11278591B2/en
... hepatic parenchyma or macrophages, can lead to iron overload. Iron ... elevated liver enzymes, and elevated iron (serum iron, serum ferritin). A ...

WO2022204535A1 - Hydrodynamic gene delivery - Google Patents

https://patents.google.com/patent/WO2022204535A1/en
... causing only mild elevations in liver enzyme levels. Catheter design and ... Thus, liver enzymes can be useful biomarker to ascertain if effective ...

US9498486B1 - Method for controlled release oral dosage of a ...

https://patents.google.com/patent/US9498486B1/en
Excessive hormone levels can lead to abnormally elevated urine calcium (hypercalciuria), blood calcium (hypercalcemia) and blood phosphorus (hyperphosphatemia).

US11118167B2 - Enzyme-mediated depletion of adenosine and/or ...

https://patents.google.com/patent/US11118167B2/en?oq=11%2C118%2C167
The present invention concerns the engineering of mammalian MTAP or prokaryotic MTAN enzymes (i.e., MTase enzymes) such that ADO and/or MTA can be efficiently ...

US8383103B2 - Botulinum toxin compositions and methods ...

https://patents.google.com/patent/US8383103B2/en
Chronic, low-level inflammation can lead to a chronic cholecystitis, where the gallbladder is fibrotic and calcified. In order to gain access and visualize ...

US9629821B2 - Treatment and prevention of liver disease ...

https://patents.google.com/patent/US9629821B2/en
... liver and can cause severe diseases such as chronic hepatitis and hepatic cirrhosis. ... elevated serum levels of liver-specific enzymes such as the ...

WO2018160739A1 - Antifibrotic activity of cd47 blockade - Google ...

https://patents.google.com/patent/WO2018160739A1/en
Fibrosis can lead to permanent scarring, organ malfunction and, ultimately, death, as seen in end-stage liver disease, kidney disease, idiopathic pulmonary ...

US10696956B2 - Engineered DNase enzymes and use in therapy ...

https://patents.google.com/patent/US10696956B2/en
... gallbladder, and liver. As such, the present invention is useful for ... removed using High Capacity Endotoxin Removal Spin Columns (both Thermo Scientific).